Century Therapeutics
CompanyUnited StatesFounded 2018
Century Therapeutics develops one asset, preclinical (CNTY-813 in type 1 diabetes). Mostly cell therapy; based in the United States, founded in 2018.
- 1
- Asset
- Furthest stage
- Preclinical
- 0
- Trials
- 0
- Signals
Pipeline
1iPSC-derived islet replacement therapy for type 1 diabetes
Preclinical, Cell therapy, type 1 diabetes
Full company profiles: pipeline, trials, funding and people.
In the full profile
- Similar companies6